Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9897)
All Articles published online
|
Publishing Process of This Article
|
Oct 28, 2016 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Meijer B, Mulder CJ, Peters GJ, van Bodegraven AA, de Boer NK. Efficacy of thioguanine treatment in inflammatory bowel disease: A systematic review. World J Gastroenterol 2016; 22(40): 9012-9021 [PMID: 27833392 DOI: 10.3748/wjg.v22.i40.9012] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i40/9012.htm |
| Number | Citing Articles |
| 1 |
Godefridus J. Peters. Nucleo(s)tide metabolism as basis for drug development; the Anne Simmonds award lecture. Nucleosides, Nucleotides & Nucleic Acids 2024; 43(8): 696 doi: 10.1080/15257770.2024.2383681
|
| 2 |
Ahmed B. Bayoumy, Melek Simsek, Margien L. Seinen, Chris J.J. Mulder, Azhar Ansari, Godefridus J. Peters, Nanne K. De Boer. The continuous rediscovery and the benefit–risk ratio of thioguanine, a comprehensive review. Expert Opinion on Drug Metabolism & Toxicology 2020; : 1 doi: 10.1080/17425255.2020.1719996
|
| 3 |
Vishal Sharma, Saurabh Kedia, Vineet Ahuja. Personalized medicine to implementation science: Thiopurines set for the leap. JGH Open 2022; 6(10): 651 doi: 10.1002/jgh3.12829
|
| 4 |
Caleb D. Swaim, Varun Dwivedi, Yi-Chieh Perng, Xu Zhao, Larissa A. Canadeo, Houda H. Harastani, Tamarand L. Darling, Adrianus C.M. Boon, Deborah J. Lenschow, Viraj Kulkarni, Jon M. Huibregtse. 6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro. iScience 2021; 24(10): 103213 doi: 10.1016/j.isci.2021.103213
|
| 5 |
Edvin Brusač, Mario-Livio Jeličić, Daniela Amidžić Klarić, Biljana Nigović, Sabina Keser, Ana Mornar. Development of a HPLC-DAD stability-indicating method and compatibility study of azathioprine and folic acid as a prerequisite for a monolayer fixed-dose combination. Analytical Methods 2021; 13(11): 1422 doi: 10.1039/D1AY00294E
|
| 6 |
E H J Savelkoul, M H J Maas, A R Bourgonje, F Crouwel, V B C Biemans, N den Broeder, M G V M Russel, T E H Römkens, N K de Boer, G Dijkstra, F Hoentjen. Favourable Tolerability and Drug Survival of Tioguanine Versus Methotrexate After Failure of Conventional Thiopurines in Crohn’s Disease. Journal of Crohn's and Colitis 2022; 16(9): 1372 doi: 10.1093/ecco-jcc/jjac044
|
| 7 |
Debbie S. Deben, Dennis R. Wong, Adriaan A. van Bodegraven. Current status and future perspectives on the use of therapeutic drug monitoring of thiopurine metabolites in patients with inflammatory bowel disease. Expert Opinion on Drug Metabolism & Toxicology 2021; 17(12): 1433 doi: 10.1080/17425255.2021.2029406
|
| 8 |
Sofia A. W. van Moorsel, Debbie S. Deben, Rob H. Creemers, Bjorn Winkens, Paul Bus, Marieke J. Pierik, Melek Simsek, Nanne K. H. de Boer, Adriaan A. van Bodegraven, Dennis R. Wong. Predictive Algorithm for Thiopurine-Induced Hepatotoxicity in Inflammatory Bowel Disease Patients. Therapeutic Drug Monitoring 2022; 44(6): 747 doi: 10.1097/FTD.0000000000001031
|
| 9 |
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments. World Journal of Gastroenterology 2017; 23(33): 6030-6048 doi: 10.3748/wjg.v23.i33.6030
|
| 10 |
Albert J. Czaja. Review article: opportunities to improve and expand thiopurine therapy for autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 2020; 51(12): 1286 doi: 10.1111/apt.15743
|
| 11 |
Xu Teng, Yingying Qi, Jing Li, Jie Wu. Effect of Exclusive Enteral Nutrition on Th17 Cells in Juvenile Rats with Inflammatory Bowel Disease. Inflammation 2021; 44(1): 261 doi: 10.1007/s10753-020-01328-4
|
| 12 |
Ali Eqbal, Alicia Martin, James D. Doecke, Desmond Patrick. Low‐dose thioguanine guided by therapeutic drug monitoring is a safe and effective alternative in inflammatory bowel disease patients intolerant to conventional thiopurines. Internal Medicine Journal 2023; 53(4): 559 doi: 10.1111/imj.15639
|
| 13 |
Ioana Păunică. Diagnostic and treatment difficulties in Crohn’s disease. Journal of Clinical and Investigative Surgery 2016; 1(2): 47 doi: 10.25083/2559.5555.12.713
|
| 14 |
Alexander T. Elford, Stephanie Dimovski, Britt Christensen. Tricks and traps of thioguanine: a case report of myelotoxicity. Internal Medicine Journal 2023; 53(6): 1089 doi: 10.1111/imj.16113
|
| 15 |
Floris F. van den Brand, Carin M. J. van Nieuwkerk, Bart J. Verwer, Ynto S. de Boer, Nanne K. H. de Boer, Chris J. J. Mulder, Elisabeth Bloemena, Christine M. Bakker, Jan M. Vrolijk, Joost P. H. Drenth, Adriaan C. I. T. L. Tan, Frank ter Borg, Martijn J. ter Borg, Sven J. van den Hazel, Akin Inderson, Maarten E. Tushuizen, Gerd Bouma. Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands. Alimentary Pharmacology & Therapeutics 2018; 48(7): 761 doi: 10.1111/apt.14939
|
| 16 |
Tomohiro Fukuda, Makoto Naganuma, Shinya Sugimoto, Kosaku Nanki, Shinta Mizuno, Makoto Mutaguchi, Yoshihiro Nakazato, Nagamu Inoue, Haruhiko Ogata, Yasushi Iwao, Takanori Kanai, Emiko Mizoguchi. The risk factor of clinical relapse in ulcerative colitis patients with low dose 5-aminosalicylic acid as maintenance therapy: A report from the IBD registry. PLOS ONE 2017; 12(11): e0187737 doi: 10.1371/journal.pone.0187737
|
| 17 |
Sheriff Umar, Xavier Welch, Chihurumanya Obichere, Brandon Carter-Cooper, Alexander Samokhvalov. Interaction of 6-Thioguanine with Aluminum Metal–Organic Framework Assisted by Mechano-Chemistry, In Vitro Delayed Drug Release, and Time-Dependent Toxicity to Leukemia Cells. Nanomaterials 2024; 14(19): 1571 doi: 10.3390/nano14191571
|
| 18 |
Helena Gensmyr-Singer, Mårten Werner, Pontus Karling. The drug-survival of low-dose thioguanine in patients with inflammatory bowel disease: a retrospective observational study. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241228064
|
| 19 |
Meiran Chu, Xinglan An, Daoyu Zhang, Qi Li, Xiangpeng Dai, Hao Yu, Ziyi Li. Combination of the 6-thioguanine and disulfiram/Cu synergistically inhibits proliferation of triple-negative breast cancer cells by enhancing DNA damage and disrupting DNA damage checkpoint. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2022; 1869(2): 119169 doi: 10.1016/j.bbamcr.2021.119169
|
| 20 |
Graziella Guariso, Marco Gasparetto. Treating children with inflammatory bowel disease: Current and new perspectives. World Journal of Gastroenterology 2017; 23(30): 5469-5485 doi: 10.3748/wjg.v23.i30.5469
|
| 21 |
Heike E. F. Becker, Karlijn Demers, Luc J. J. Derijks, Daisy M. A. E. Jonkers, John Penders. Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1107976
|
| 22 |
Jeroen P.A. Houwen, Antoine C.G. Egberts, Anthonius de Boer, Erik M. van Maarseveen, Roderick H.J. Houwen, Arief Lalmohamed. Influence of allopurinol on thiopurine associated toxicity: A retrospective population‐based cohort study. British Journal of Clinical Pharmacology 2021; 87(5): 2333 doi: 10.1111/bcp.14625
|
| 23 |
Carla J. Gargallo-Puyuelo, Viviana Laredo, Fernando Gomollón. Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era?. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.681907
|
| 24 |
Paula Sousa, Nurulamin M Noor. Revisiting Drug Development for Older Molecules in IBD. Inflammatory Bowel Diseases 2023; 29(6): 1012 doi: 10.1093/ibd/izac220
|
| 25 |
Abhinav Vasudevan, Danny Con, Daniel R. van Langenberg. Letter: Thioguanine, an under‐utilised option in inflammatory bowel disease? Authors' reply. Alimentary Pharmacology & Therapeutics 2024; 59(8): 1011 doi: 10.1111/apt.17957
|
| 26 |
Nanne K H de Boer, Laurent Peyrin-Biroulet, Bindia Jharap, Jeremy D Sanderson, Berrie Meijer, Imke Atreya, Murray L Barclay, Jean-Frederic Colombel, Anthony Lopez, Laurent Beaugerie, Anthony M Marinaki, Adriaan A van Bodegraven, Markus F Neurath. Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives. Journal of Crohn's and Colitis 2018; 12(5): 610 doi: 10.1093/ecco-jcc/jjx181
|
| 27 |
Femke Crouwel, Ahmed B Bayoumy, Chris J J Mulder, Job H C Peters, Paul J Boekema, Luc J J Derijks, Sybrand Y de Boer, Paul C van de Meeberg, Ishfaq Ahmad, Hans J C Buiter, Nanne K de Boer. The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naïve Inflammatory Bowel Disease Patients. Inflammatory Bowel Diseases 2024; 30(9): 1492 doi: 10.1093/ibd/izad197
|
| 28 |
Melek Simsek, Berrie Meijer, Adriaan A. van Bodegraven, Nanne K.H. de Boer, Chris J.J. Mulder. Finding hidden treasures in old drugs: the challenges and importance of licensing generics. Drug Discovery Today 2018; 23(1): 17 doi: 10.1016/j.drudis.2017.08.008
|
| 29 |
Gerassimos J. Mantzaris. Thiopurines and Methotrexate Use in IBD Patients in a Biologic Era. Current Treatment Options in Gastroenterology 2017; 15(1): 84 doi: 10.1007/s11938-017-0128-0
|
| 30 |
Hongyan Zeng, Li Li, Yaping Ding, Qi Zhuang. Simple and selective determination of 6-thioguanine by using polyethylenimine (PEI) functionalized carbon dots. Talanta 2018; 178: 879 doi: 10.1016/j.talanta.2017.09.087
|
| 31 |
Nanne K H de Boer, Melek Simsek, Berrie Meijer, Markus F Neurath, Ad van Bodegraven, Chris J J Mulder. Drug rediscovery in gastroenterology: from off-label to on-label use of thioguanine in inflammatory bowel disease. Gut 2023; 72(10): 1985 doi: 10.1136/gutjnl-2023-329679
|
| 32 |
Ashkan Rezazadeh Ardabili, Steven Jeuring, Zlatan Mujagic, Liekele Oostenbrug, Mariëlle Romberg‐Camps, Daisy Jonkers, Adriaan van Bodegraven, Marieke Pierik. Classic drugs in the time of new drugs: real‐world, long‐term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2022; 56(6): 1030 doi: 10.1111/apt.17128
|
| 33 |
Anuraag Jena, Pardhu B Neelam, Harshavardhan Telaprolu, Uday Kiran Mangipudi, Usha Dutta, Shaji Sebastian, Vishal Sharma. Effectiveness and safety of thioguanine as a maintenance therapy of inflammatory bowel disease: Systematic review, meta-analysis and meta-regression. Clinics and Research in Hepatology and Gastroenterology 2023; 47(7): 102155 doi: 10.1016/j.clinre.2023.102155
|
| 34 |
Femke Crouwel, Hans J C Buiter, Nanne K H de Boer. There is still a place for optimised thiopurine therapy in IBD. Gut 2021; 70(11): 2207 doi: 10.1136/gutjnl-2020-323481
|
| 35 |
Femke Crouwel, Hans J C Buiter, Nanne K de Boer. The Thiopurine Tale: An Unexpected Journey. Journal of Crohn's and Colitis 2022; 16(7): 1177 doi: 10.1093/ecco-jcc/jjac004
|
| 36 |
Tingting Qiu, Huibo Li, Tong Sun, Peng Men, Xiangli Cui, Cuiwen Liu, Suodi Zhai. Thalidomide as a treatment for inflammatory bowel disease in children and adolescents: A systematic review. Journal of Clinical Pharmacy and Therapeutics 2020; 45(5): 1134 doi: 10.1111/jcpt.13196
|
| 37 |
Ramya Movva, Alison Haywood, Sohil A Khan, Timothy HJ Florin, Iulia Oancea. Critical assessment of thioguanine treatment for inflammatory bowel diseases: Is it time to rehabilitate this treatment?. Journal of Digestive Diseases 2017; 18(9): 529 doi: 10.1111/1751-2980.12536
|
| 38 |
Melek Simsek, Femke Schepers, Sigal Kaplan, Dirk van Asseldonk, Petra van Boeckel, Paul Boekema, Gerard Dijkstra, Herma Fidder, Ingrid Gisbertz, Frank Hoentjen, Bindia Jharap, Frank Kubben, Marleen de Leest, Maarten Meijssen, Ana Petrak, Else van de Poel, Maurice Russel, Adriaan A van Bodegraven, Chris J J Mulder, Nanne de Boer. Thioguanine is Effective as Maintenance Therapy for Inflammatory Bowel Disease: A Prospective Multicentre Registry Study. Journal of Crohn's and Colitis 2023; 17(6): 933 doi: 10.1093/ecco-jcc/jjad013
|
| 39 |
Yuichiro Kojima, Yosuke Hirotsu, Wataru Omata, Makoto Sugimori, Shinya Takaoka, Hiroshi Ashizawa, Keiko Nakagomi, Dai Yoshimura, Kenji Hosoda, Yoji Suzuki, Hitoshi Mochizuki, Masao Omata. Influence of <i>NUDT15</i> variants on hematological pictures of patients with inflammatory bowel disease treated with thiopurines. World Journal of Gastroenterology 2018; 24(4): 511-518 doi: 10.3748/wjg.v24.i4.511
|
| 40 |
Chunhe Yu, Xiaohua Jiang, Dongmiao Qin, Guichun Mo, Xiangfei Zheng, Biyang Deng. Facile Syntheses of S,N-Codoped Carbon Quantum Dots and Their Applications to a Novel Off–On Nanoprobe for Detection of 6-Thioguanine and Its Bioimaging. ACS Sustainable Chemistry & Engineering 2019; 7(19): 16112 doi: 10.1021/acssuschemeng.9b02886
|
| 41 |
Sjoerd de Hoogd, Dennis R. Wong, Durk R. de Vries, Ankie M. Harmsze. Severe pancytopenia and aspergillosis caused by thioguanine in a thiopurine S-methyltransferase deficient patient: a case report. European Journal of Gastroenterology & Hepatology 2019; 31(12): 1592 doi: 10.1097/MEG.0000000000001504
|
| 42 |
Tim Raine, Bram Verstockt, Uri Kopylov, Konstantinos Karmiris, Rimma Goldberg, Raja Atreya, Johan Burisch, John Burke, Pierre Ellul, Charlotte Hedin, Stefan D Holubar, Konstantinos Katsanos, Triana Lobaton, Carsten Schmidt, Garret Cullen. ECCO Topical Review: Refractory Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2021; 15(10): 1605 doi: 10.1093/ecco-jcc/jjab112
|
| 43 |
Wenjing Chen, Jun Fan, Xianxue Wu, Dongbao Hu, Yunying Wu, Zhongmin Feng, Meiyun Yan, Xizhu Gao, Jianxin Xie. Facile synthesis of nitrogen-doped carbon dots from pork liver and its sensing of 6-thioguanine based on the inner filter effect. New Journal of Chemistry 2021; 45(11): 5114 doi: 10.1039/D0NJ05483F
|
| 44 |
Nanne K.H. de Boer, Vineet Ahuja, Sven Almer, Azhar Ansari, Rupa Banerjee, Murray L. Barclay, Jake Begun, Adriaan A. van Bodegraven, Jean-Frederic Colombel, David P. Epstein, Timothy H.J. Florin, Richard B. Gearry, Javier P. Gisbert, Rupert W. Leong, Chris J.J. Mulder, Markus F. Neurath, Graham L. Radford-Smith, Margien L. Seinen, Melek Simsek, Miles P. Sparrow. Thiopurine Therapy in Inflammatory Bowel Diseases: Making New Friends Should Not Mean Losing Old Ones. Gastroenterology 2019; 156(1): 11 doi: 10.1053/j.gastro.2018.11.039
|
| 45 |
Diego Vergani, Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani. A reasoned approach to the treatment of autoimmune hepatitis. Digestive and Liver Disease 2021; 53(11): 1381 doi: 10.1016/j.dld.2021.05.033
|
| 46 |
Burton I. Korelitz, David B. Sachar, Judy Schneider. Full Potential of 6-Mercaptopurine in IBD May Remain Untapped. American Journal of Gastroenterology 2020; 115(12): 2109 doi: 10.14309/ajg.0000000000000769
|
| 47 |
Ahmed B. Bayoumy, Elsa L. S. A. van Liere, Melek Simsek, Ben Warner, Aathavan Loganayagam, Jeremy D. Sanderson, Simon Anderson, Jonathan Nolan, Nanne K. de Boer, Chris J. J. Mulder, Azhar Ansari. Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01441-6
|
| 48 |
Zhaojie Li, Chuantao Peng, Yaru Sun, Tao Zhang, Cuijiao Feng, Weiqin Zhang, Tian Huang, Guoqiang Yao, Heping Zhang, Qiuwen He, Francesca Turroni.
Both viable
Bifidobacterium longum
subsp.
infantis
B8762 and heat-killed cells alleviate the intestinal inflammation of DSS-induced IBD rats
. Microbiology Spectrum 2024; 12(6) doi: 10.1128/spectrum.03509-23
|
| 49 |
Vince B. C. Biemans, Edo Savelkoul, Ruben Y. Gabriëls, Melek Simsek, Gerard Dijkstra, Marieke J. Pierik, Rachel L. West, Nanne K.H. de Boer, Frank Hoentjen. A comparative analysis of tioguanine versus low‐dose thiopurines combined with allopurinol in inflammatory bowel disease patients. Alimentary Pharmacology & Therapeutics 2020; 51(11): 1076 doi: 10.1111/apt.15730
|
| 50 |
Femke Crouwel, Melek Simsek, Amarylle S van Doorn, Chris J J Mulder, Hans J C Buiter, Murray L Barclay, Timothy H Florin, Nanne K de Boer. Rectally Administrated Thioguanine for Distal Ulcerative Colitis: A Multicenter Case Series. Inflammatory Bowel Diseases 2023; 29(6): 1000 doi: 10.1093/ibd/izac195
|
| 51 |
Melek Simsek, Debbie S. Deben, Carmen S. Horjus, Melanie V. Bénard, Birgit I. Lissenberg‐Witte, Hans J. C. Buiter, Matthijs van Luin, Margien L. Seinen, Chris J. J. Mulder, Dennis R. Wong, Nanne K. H. de Boer, Adriaan A. van Bodegraven. Sustained effectiveness, safety and therapeutic drug monitoring of tioguanine in a cohort of 274 IBD patients intolerant for conventional therapies. Alimentary Pharmacology & Therapeutics 2019; 50(1): 54 doi: 10.1111/apt.15280
|
| 52 |
Kirtesh Pratap Khare, Rachana Kathal, Neelima Shukla, Reena Srivastava, Anurag Srivastava. Suitability of ZnO Nanocomposite of Copolymer (PPy-PNVK-ZnO) (PPy = Polypyrrole;
PNVK = Poly 9-vinyl carbazole) for the Detection of 6-Thioguanine: A DFT Analysis. Asian Journal of Chemistry 2023; 35(2): 422 doi: 10.14233/ajchem.2023.26881
|
| 53 |
Mohammad Shir Ali, Robyn Laube, Sriharan Selvaratnam, Rupert W. Leong. Tioguanine as an alternative immunomodulator in inflammatory bowel diseases. Internal Medicine Journal 2020; 50(11): 1434 doi: 10.1111/imj.15057
|
| 54 |
Nicola Pugliese, Lucia Giuli, Elisabetta Mastrorocco, Francesco Santopaolo, Giacomo Marcozzi, Cristina Bezzio, Arianna Dal Buono, Roberto Gabbiadini, Antonio Gasbarrini, Francesca Romana Ponziani, Alessandro Armuzzi, Alessio Aghemo. Exploring the link: Porto-sinusoidal vascular disorder and inflammatory bowel disease – A comprehensive narrative review. Digestive and Liver Disease 2024; 56(6): 964 doi: 10.1016/j.dld.2023.11.021
|